High-dose chemotherapy with stem cell support

Not advantageous in the treatment of patients with breast cancer and 10 or more positive lymph nodes compared to standard adjuvant chemotherapy.

Mortality in expert centers 1-2%.

Acute leukemia and myelodysplastic syndromes occur in 4-7% of treated patients.

Leave a Reply

Your email address will not be published. Required fields are marked *